Clinical Trials on Paraproteinemias in South Africa
Total 270 results
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple Myeloma | Non-Hodgkin's LymphomaIsrael, Italy, Poland, South Africa, United Kingdom
-
Senesco Technologies, Inc.UnknownMultiple Myeloma | Plasma Cell Leukemia | Multiple Myeloma in Relapse | Mantle Cell Lymphoma in Relapse | Diffuse Large B Cell Lymphoma in Relapse | Other B Cell Lymphoma in RelapseUnited States, South Africa
-
Hellenic Society of HematologyTakeda; Janssen Pharmaceutica NVUnknown
-
Hellenic Society of HematologyJanssen PharmaceuticalsUnknown
-
Hellenic Society of HematologyGlaxoSmithKlineActive, not recruiting
-
Meletios A. DimopoulosCompleted
-
University of AthensPierre and Marie Curie UniversityRecruitingMultiple Myeloma | Venous ThromboembolismGreece
-
Hellenic Society of HematologyJanssen PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaGreece
-
Medical University of South CarolinaGenentech, Inc.CompletedMultiple MyelomaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingMultiple MyelomaAustralia
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of CopenhagenActive, not recruiting
-
Prothena Biosciences Ltd.Amyloidosis Research Consortium; Amyloidosis Support Groups; Amyloidosis Foundation and other collaboratorsCompletedAL Amyloidosis | AmyloidosisUnited States
-
Meletios A. DimopoulosEuropean Myeloma NetworkCompletedWaldenstrom's MacroglobulinemiaSpain, Greece, Netherlands
-
Gary MorrowNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedMultiple Myeloma | InfectionUnited States, Peru, South Africa
-
University of Alabama at BirminghamAmgenCompletedMultiple MyelomaUnited States
-
Hoosier Cancer Research NetworkNovartis Pharmaceuticals; Walther Cancer InstituteTerminatedMultiple MyelomaUnited States
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
AmgenCompletedMultiple MyelomaGreece, Italy, Netherlands
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
National University Hospital, SingaporeCelgene; International Myeloma Foundation; The Australasian Leukaemia & Lymphoma...UnknownRelapsed and/or Refractory Multiple MyelomaSingapore, Hong Kong, Korea, Republic of, Taiwan
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Cylene PharmaceuticalsUnknownMultiple MyelomaUnited States
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
Pharmacyclics LLC.Celgene CorporationTerminatedMultiple MyelomaUnited States, Spain, Australia, Czechia, Germany, Greece
-
Genentech, Inc.RecruitingMultiple MyelomaSpain, Australia, Denmark, Norway
-
GlaxoSmithKlineIqvia Pty LtdActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
AbbVieGenentech, Inc.; Celgene CorporationWithdrawnMultiple MyelomaUnited States, Australia, Canada, Spain
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)CompletedDexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmUnited States, Puerto Rico, South Africa
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Puerto Rico, South Africa
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
K-Group Alpha, Inc., a wholly owned subsidiary...Active, not recruitingAL Amyloidosis | AmyloidosisSpain, Australia, Israel, United States, Greece, Italy, Cyprus
-
CelgeneCompletedMelanoma | Lymphoma | Multiple Myeloma | Pancreatic Cancer | Non-Small Cell Lung CancerAustralia
-
Bristol-Myers SquibbCompleted
-
zr Pharma & GmbHCompletedMultiple MyelomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCWithdrawnRecurrent Plasma Cell MyelomaUnited States
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationActive, not recruitingMyeloma, MultipleUnited States
-
Human Genome Sciences Inc.CompletedMultiple MyelomaUnited States, Canada, Australia, India
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Poland, Greece, Australia, Sweden
-
Seagen Inc.Genentech, Inc.CompletedMultiple MyelomaUnited States
-
Alaunos TherapeuticsUnknownMultiple MyelomaUnited States
-
Xcyte TherapiesCompleted
-
Innate PharmaCompletedPatients With Multiple Myeloma Experiencing a | First or Second RelapseUnited States
-
Genentech, Inc.RecruitingMultiple MyelomaAustralia, Spain, Israel, Korea, Republic of, Greece, Norway, Denmark
-
Hoffmann-La RocheRecruitingMultiple MyelomaKorea, Republic of, Australia, Spain, France, Poland
-
CRISPR Therapeutics AGActive, not recruitingMultiple MyelomaUnited States, Spain, Australia, Canada
-
CelgeneCompletedMultiple MyelomaIndia, Philippines, France, Portugal, Poland, South Africa, Bulgaria, Croatia, Czechia, Germany, Hungary, Italy, Serbia, Slovakia, United Kingdom